Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Moyco CMP Slurries - CEO Says -- Ignore unavailable to you. Want to Upgrade?

To: straight life who wrote (474)	8/3/1999 11:03:00 AM
From: Mel Spivak	Respond to of 534

Some hope for the CMP slurries from CEM's recent report: Electronic and Other Specialty Chemicals operating profits were $4.3 million for the quarter, about the same as last year, and up 22 percent from prior quarter on better results in other specialties. Operating profits for the six months were $7.8 million versus $10 million last year on a 5 percent sales decline to $87 million. Second quarter electronic chemical volumes were up solidly compared to prior quarter and last year, reflecting an improving semiconductor industry. However, results for the six months were hurt by lower average prices and additional costs for product development and new R & D and engineering facilities in the U.S. and Japan.